Coronavirus business update Get 30 days’ complimentary access to our Coronavirus Business Update newsletter 30 days complimentary
Add this topic to your myFT Digest for news straight to your inbox
Voters may not distinguish between populist virus-deniers and science-led technocrats
Hunger and disease are beckoning in small and fragile states
Restrictions cause dismay in Spain and anger tourism industry
The prime minister warned the virus could derail decades of progress. But new infections are now at record levels
Republicans are set to unveil their proposals for a fresh round of US stimulus today
If the £1.5bn was spent earlier it could have freed the equivalent of 28,000 beds, says think-tank
Move comes as country struggles with new wave of coronavirus infections
Friday’s fatality count caps grim week in which Donald Trump conceded seriousness of outbreak
Delinquencies on car loans, credit cards and student loans have remained low so far
The Oxford scientist has devoted her career to combating deadly pathogens with pandemic potential
Prime minister concedes lessons need to be learned about how early stages of pandemic were handled
Mis-steps and weaknesses exposed as Spanish region endures new round of restrictions
There has been notable progress on the clinical trial front this week. Our reporters break down what it all means
President reverses course as latest pandemic milestone underlines disease’s rapid spread
Doses secured to inoculate 30m people, which will also be offered to over-50s in England for first time
For one, it builds expertise. Vietnam’s Sars ‘dividend’ has helped keep its Covid-19 deaths at zero
Pandemic offers world leaders an opportunity to rebuild faith in liberal democracy
Questions over immunity and eligibility and lack of clear strategy leave manufacturers in limbo
Record increase in Texas deaths as more states and cities issue broad mask guidelines
Matt Hancock ready to reform PHE as criticism of its response to coronavirus crisis mounts
Patients in the US are waiting more than a week for results, by which time it’s probably too late
BioNTech and Pfizer announce deal for 100m doses of coronavirus inoculation candidate
Executives among those granted special treatment in bid to maintain economic growth
